Moreover, treatment with AT1R blockers has been reported to be associated with longer progression free survival and overall survival in patients with advanced pancreatic cancer and colon cancer (Mc Menamin et al., 2012[30]; Nakai et al., 2013[35]). Here, AGTR1 is linked to malignant colon neoplasm.